Western Izmir’s Ege University’s (EU) Vaccine Research and Development Team has started testing the antigens they’ve developed for a COVID-19 DNA vaccine, they said April 14.
“We’ve completed antigen design, which is the first step in our work. We will determine the effectiveness of the DNA vaccine we will develop with these antigens and we hope to start animal trials in four months,” EU Medicine Faculty Lecturer Dr. Mert Döşkaya said.Three Turkish universities collaborating on a coronavirus vaccine
The World Health Organization (WHO) said that more than 50 institutions around the globe, Döşkaya noted, adding that the work being carried out in Turkey are approximately at the same stage as others around the world.
“Five experiments have entered the clinical stage, meaning they’re conducting human trials. Others are preparing for animal trials.”
The EU Vaccine Research and Development Team was founded two and a half years ago, and it involves 32 scientists from local universities, the Health Ministry and the Agriculture and Forestry Ministry, as well as local research centers.Turkey's Ankara University accomplishes first step toward COVID-19 vaccineGerman biotech company owned by Turkish scientist signs deal with Chinese pharmaceutical firm for coronavirus vaccine